Loading live market data…

Shuttle Pharmaceuticals Holdings, Inc.

NASDAQ:SHPH

$4.09 USD

$1.13 (38.18%)

Volume
52.89M
Average Volume
1.13M
Market Capitalization
$2.39M
P/E Ratio
-0.07
Dividend Yield
0.00%
Price Target
$
Year High
$55.90
Year Low
$2.71
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.30

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO Christopher Robert Cooper
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Current Symbol SHPH
CUSIP 825693500
CIK 0001757499
Web https://www.shuttlepharma.com
Phone 240 403 4212
Currency USD
Employees 2
Country US

Liquidity

Debt-to-Equity Ratio 0.06
Payout Ratio 0.00
Current Ratio 0.30
Quick Ratio 0.30
Cash Ratio 0.13

Sales & Book Value

Annual Sales $-
Price / Sales 0.00
Cash Flow -18.63
Price / Cash Flow -0.26
Price / Book 0.61

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-71.6
Trailing P/E Ratio -0.07
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-11.72M
Net Margin 0.00%
Pretax Margin 0.00%
Return on Equity -408.33%
Return on Assets -91.63%

Financials Score

AltmanZ Score -9.23
Piotroski Score 1.00
Working Capital -5.84M
Total Assets 11.81M
Ebit -10.75M
Market Cap 1.64M
Total Liabilities 8.46M

Poll Results

About Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Stock

Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancerous cells to radiation therapy. Its current portfolio of clinical-phase treatments features Ropidoxuridine, an orally administered halogenated pyrimidine, which is intended for individuals afflicted with brain tumors and soft tissue sarcomas. Additionally, the company is progressing Doranidazole, an injectable compound designed to make oxygen-deprived tumor cells more responsive to radiation, targeting malignancies of the pancreas, lungs, and liver. This enterprise was established in 2012 and maintains its principal operations in Rockville, Mar ... yland.

United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site

2026-06-26 08:00:00

United Dogecoin looks to have its miners operational within approximately 60 days, leveraging low-cost, renewable energy, on its path to being the market's largest Dogecoin miner by hashrate Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle"), has completed two significant milestones on its projected path to market scale and operational excellence. United Dogecoin has purchased its first fleet of ElphaPex DG1+ mining units, which the Company believes are among the most powerful and efficient Dogecoin miners available.

United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting

2026-06-25 16:05:00

United Dogecoin shares insights on its digital infrastructure strategy, aimed at expanding revenue opportunities and supporting long-term shareholder value creation. Gaithersburg, Maryland--(Newsfile Corp. - June 25, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining and digital infrastructure company driven by industry experts recently acquired by Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle"), has initiated an evaluation of proprietary data centre and power generation opportunities designed to support long-term DOGE mining operations and future AI infrastructure workloads.

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

2026-06-09 08:30:00

Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early-stage drug development, and United Dogecoin, Inc., Shuttle Pharma's wholly owned subsidiary and a Dogecoin mining company, today announced that its board of directors have approved a proposed reverse stock split of its common stock at a ratio of 10-for-1. The reverse stock split will become effective on June 11, 2026, at 12:01 a.m.

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

2026-05-14 16:05:00

Initial Mining Fleet Targeted for Deployment Within 60 Days of Receipt; To Mine DOGE and LTC and Accumulate Mined Coins as Long-Term Treasury Assets Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously announced merger with United Dogecoin Inc. ("United Dogecoin"), and the confirmation of a purchase order granting the Company the option to purchase up to 3,000 next-generation ElphaPex Scrypt mining rigs ("Mining Rigs") for use in the Company's Dogecoin (DOGE) and Litecoin (LTC) merge-mining operations. As previously reported on Shuttle's Current Report on Form-8-K dated May 7, 2026 (the "Closing 8-K"), filed with the U.S. Securities and Exchange Commission (the "SEC"), the Closing was completed on May 6, 2026.

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

2026-05-07 14:02:00

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced it served as exclusive M&A advisor and placement agent in connection with the successful closing of Shuttle Pharmaceuticals Holdings, Inc.'s (NASDAQ: SHPH) acquisition of United Dogecoin Inc. (“United Dogecoin” or the “Company”), a Dogecoin mining company driven by industry experts.

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

2026-05-01 08:41:00

The combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrate Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle.

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

2026-04-30 16:05:00

The combination and related financing is expected to result in the largest publicly listed Dogecoin mining company based on percentage of the global hashrate Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts. United Dogecoin will be merged into a wholly owned subsidiary of Shuttle.

Short Interest in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Drops By 38.6%

2026-04-27 05:38:47

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totaling 71,193 shares, a drop of 38.6% from the March 31st total of 115,865 shares. Based on an average daily trading volume, of 156,443 shares, the days-to-cover ratio is

Frequently Asked Questions

What is the current Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock price?

Shuttle Pharmaceuticals Holdings, Inc.(NASDAQ:SHPH) stock price is $4.09 in the last trading session. During the trading session, SHPH stock reached the peak price of $55.9 while $2.71 was the lowest point it dropped to. The percentage change in SHPH stock occurred in the recent session was 38.18% while the dollar amount for the price change in SHPH stock was $1.13.

SHPH's industry and sector of operation?

The NASDAQ listed SHPH is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of SHPH?

Tyvin A. Rich | Chief Clinical Officer & Chief Medical Officer
Michael Vander Hoek | Vice President for Operations and Regulatory
Mira Jung | Co-Founder & Chief Scientific Officer for Biology
Christopher Robert Cooper | Interim CEO & Director
Yuying Liang | Chief Financial Officer

How many employees does SHPH have?

Number of SHPH employees currently stands at 2. SHPH operates from One Research Court, Gaithersburg, MD 20850, US.

Link for SHPH official website?

Official Website of SHPH is: https://www.shuttlepharma.com

How do I contact SHPH?

SHPH could be contacted at phone #240 403 4212 and can also be accessed through its website. SHPH operates from One Research Court, Gaithersburg, MD 20850, US.

How many shares of SHPH are traded daily?

The average number of SHPH shares traded daily for last 3 months was 1.13M.

What is the market cap of SHPH currently?

The market value of SHPH currently stands at $2.39M with its latest stock price at $4.09